Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.51 |
| ▸ | CA1 | P00915 | 5/20 | 0.51 |
| ▸ | CA2 | P00918 | 5/20 | 0.51 |
| ▸ | CA9 | Q16790 | 5/20 | 0.51 |
| ▸ | NQO2 | P16083 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | CYP3A43 | Q9HB55 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.41 |
| ▸ | MIF | P14174 | 1/20 | 0.41 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19733682 | 0.95 | CA12 (0.53) | CA12CA1CA2CA9NQO2 | |
| SCHEMBL4278756 | 0.88 | CA12 (0.51) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL3156719 | 0.87 | CA12 (0.50) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL3161136 | 0.87 | CA12 (0.50) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL3155955 | 0.87 | CA12 (0.53) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL3195599 | 0.86 | CA12 (0.52) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL3156889 | 0.85 | CA12 (0.48) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL3194156 | 0.84 | CA12 (0.48) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL17958060 | 0.84 | CA12 (0.50) | CA12CA1CA2CA9PDK2 | |
| SCHEMBL3901784 | 0.84 | CA12 (0.53) | CA12CA1CA2CA9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10774262-B2 | Three-dimensional structures of mesogenic ligand-functionalized nanoparticles and methods of making and using the same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-09-15 | — | — | US | disclosed |
| US-20170362504-A1 | Three-dimensional Structures of Mesogenic Ligand-functionalized Nanoparticles and Methods of Making and Using the Same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10774262-B2 | Three-dimensional structures of mesogenic ligand-functionalized nanoparticles and methods of making and using the same | EPHA3, NECTIN4, EPHA2 | CA12 928/4885CA1 1348/4885CA2 3193/4885 |
| US-20170362504-A1 | Three-dimensional Structures of Mesogenic Ligand-functionalized Nanoparticles and Methods of Making and Using the Same | EPHA3, NECTIN4, EPHA2 | CA12 928/4885CA1 1348/4885CA2 3193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.